| Miss Amanda M Hackney, LPN | |
|
1614 Ravinia Rd, Charleston, WV 25314-1846 | |
| (304) 859-0520 | |
| Not Available |
| Full Name | Miss Amanda M Hackney |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 1614 Ravinia Rd, Charleston, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003591546 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 30005 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Amanda M Hackney, LPN 1614 Ravinia Rd, Charleston, WV 25314-1846 Ph: (304) 859-0520 | Miss Amanda M Hackney, LPN 1614 Ravinia Rd, Charleston, WV 25314-1846 Ph: (304) 859-0520 |
News Archive
COPD is defined as a preventable and treatable disease associated with significant extrapulmonary consequences that may contribute to severity. The pulmonary component of COPD is characterised by airflow limitation that is not fully reversible. The airflow limitation is usually progressive with an abnormal inflammatory response of the lungs to noxious particles (GOLD Strategy Document). Airflow obstruction in COPD is not highly variable and largely irreversible.
A robust, low-cost imaging platform utilizing lab-on-a-chip technology created by University of California, Irvine scientists may be available for rapid coronavirus diagnostic and antibody testing throughout the nation by the end of the year.
Emerging Healthcare Solutions, Inc. disclosed that the Company has received documents from Stand-By Systems affirming that their revolutionary LIFEDGE prototype is now complete and ready for pilot scale production. EHSI recently executed an option with Stand-By Systems, owner of the new FDA approved SBS 1615 catalytic oxygen generator and associated systems.
The Journal of the American Academy of Dermatology (JAAD) has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses - 2.5% and 3.75% - administered daily on a 2-week treatment cycle. The study demonstrates that both formulations were superior to placebo, and that imiquimod 3.75% on a daily 2-week treatment cycle is superior to imiquimod 2.5% in treating actinic keratosis (AK) on a large surface area - the face or balding scalp.
› Verified 3 days ago
Whitley Ryan Napier, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1599 2nd Ave, Charleston, WV 25387 Phone: 304-453-4663 Fax: 304-453-1103 | |
Jeannie Sparks, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 900 Virginia St E Ste 400, Charleston, WV 25301 Phone: 681-313-4759 Fax: 844-800-3954 | |
Deborah Honaker Ross, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 900 Virginia St E Ste 400, Charleston, WV 25301 Phone: 681-313-4759 Fax: 844-800-3954 | |
Lara Rene Ferrell, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 900 Virginia St E Ste 400, Charleston, WV 25301 Phone: 681-313-4759 Fax: 844-800-3954 | |
Abinet Aregahgn, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 900 Virginia St E Ste 400, Charleston, WV 25301 Phone: 681-313-4759 Fax: 844-800-3954 | |
Lindsey Nicole Holstein, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2345 Chesterfield Ave Ste 201, Charleston, WV 25304 Phone: 304-343-2047 |